Managing Musculoskeletal and Kidney Aging: A Call for Holistic Insights

References

• Kanis JA, Norton N, Harvey NC, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16:82. doi:10.1007/s11657-020-00871-9
   PubMed Web of Science ®Google Scholar
• Kim SM, Long J, Montez-Rath M, et al. Hip fracture in patients with non-dialysis-requiring chronic kidney disease. J Bone Miner Res off J Am Soc Bone Miner Res. 2016;31:1803–1809. doi:10.1002/jbmr.2862
   PubMed Web of Science ®Google Scholar
• Tom SE, Adachi JD, Anderson FA, et al. Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. J Am Geriatr Soc. 2013;61:327–334. doi:10.1111/jgs.12146
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56:M146–156. doi:10.1093/gerona/56.3.M146
   PubMed Web of Science ®Google Scholar
• Beaudart C, Rolland Y, Cruz-Jentoft AJ, et al. Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. 2019;105:1–14. doi:10.1007/s00223-019-00545-w
   PubMed Web of Science ®Google Scholar
• Harvey NC, Odén A, Orwoll E, et al. Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) Study. J Bone Miner Res off J Am Soc Bone Miner Res. 2018;33:2150–2157. doi:10.1002/jbmr.3556
   PubMed Web of Science ®Google Scholar
• Harvey NC, Orwoll E, Kwok T, et al. Sarcopenia definitions as predictors of fracture risk independent of FRAX, falls, and BMD in the osteoporotic fractures in men (MrOs) study: a meta‐analysis. J Bone Miner Res. 2021;36:1235–1244. doi:10.1093/ageing/afy144
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Hughes VA, Frontera WR, Roubenoff R, et al. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–481. doi:10.1093/ajcn/76.2.473
   PubMed Web of Science ®Google Scholar
• Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10:207–217. doi:10.1002/jcsm.12383
   PubMed Web of Science ®Google Scholar
• Norman K, Haß U, Pirlich M. Malnutrition in older adults—recent advances and remaining challenges. Nutrients. 2021;13:2764. doi:10.3390/nu13082764
   PubMed Web of Science ®Google Scholar
• Crichton M, Craven D, Mackay H, et al. A systematic review, meta-analysis and meta-regression of the prevalence of protein-energy malnutrition: associations with geographical region and sex. Age Ageing. 2019;48:38–48.
   PubMed Web of Science ®Google Scholar
• Leij-Halfwerk S, Verwijs MH, van Houdt S, et al. Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults ≥65 years: a systematic review and meta-analysis. Maturitas. 2019;126:80–89.
   PubMed Web of Science ®Google Scholar
• Landi F, Onder G, Russo A, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr Edinb Scotl. 2014;33:539–544. doi:10.1016/j.clnu.2013.07.013
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet Lond Engl. 2019;393:2636–2646. doi:10.1016/S0140-6736(19)31138-9
   PubMed Web of Science ®Google Scholar
• Chevalley T, Guilley E, Herrmann FR, et al. Incidence of hip fracture over a 10-year period (1991–2000): reversal of a secular trend. Bone. 2007;40:1284–1289. doi:10.1016/j.bone.2006.12.063
   PubMed Web of Science ®Google Scholar
• Kannegaard PN, van der Mark S, Eiken P, et al. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39:203–209. doi:10.1093/ageing/afp221
   PubMed Web of Science ®Google Scholar
• Lih A, Nandapalan H, Kim M, et al. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2011;22:849–858. doi:10.1007/s00198-010-1477-x
   PubMed Web of Science ®Google Scholar
• Berry SD, Ngo L, Samelson EJ, et al. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58:783–787. doi:10.1111/j.1532-5415.2010.02767.x
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Cavalier E, D’Haese PC. Biomarkers predicting bone turnover in the setting of CKD. Curr Osteoporos Rep. 2017;15:178–186. doi:10.1007/s11914-017-0362-3
   PubMed Web of Science ®Google Scholar
• Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet Lond Engl. 2014;383:146–155. doi:10.1016/S0140-6736(13)61647-5
   PubMed Web of Science ®Google Scholar
• Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet Lond Engl. 2005;365:1621–1628.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847–858. doi:10.1016/S2213-8587(18)30265-1
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. doi:10.1136/bmj.b3692
   PubMed Web of Science ®Google Scholar
• Ott SM. Review article: bone density in patients with chronic kidney disease stages 4–5. Nephrol Carlton Vic. 2009;14:395–403. doi:10.1111/j.1440-1797.2009.01159.x
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Branco J, Brandi M-L, et al. Management of osteoporosis of the oldest old. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2014;25:2507–2529. doi:10.1007/s00198-014-2755-9
   PubMed Web of Science ®Google Scholar
• Rolland Y, Cesari M, Fielding RA, et al. Osteoporosis in frail older adults: recommendations for research from the ICFSR task force 2020. J Frailty Aging. 2021;10:168–175. doi:10.14283/jfa.2021.4
   PubMed Web of Science ®Google Scholar
• Cosman F, Crittenden DB, Ferrari S, et al. FRAME study: the foundation effect of building bone with 1 year of romosozumab leads to continued lower fracture risk after transition to denosumab. J Bone Miner Res off J Am Soc Bone Miner Res. 2018;33:1219–1226. doi:10.1002/jbmr.3427
   PubMed Web of Science ®Google Scholar
• Kirsztajn GM, Suassuna JHR, Bastos MG. Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B. Kidney Int. 2009;76:462–463; author reply 463–464. doi:10.1038/ki.2009.178
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Hotchkiss JR, Kurella Tamura M, et al. Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med. 2014;174:391–397. doi:10.1001/jamainternmed.2013.13328
   PubMed Web of Science ®Google Scholar
• O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol JASN. 2007;18:2758–2765. doi:10.1681/ASN.2007040422
   PubMed Web of Science ®Google Scholar
• Corsonello A, Fabbietti P, Formiga F, et al. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance: the screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr. 2020;20:350. doi:10.1186/s12877-020-01696-4
   PubMed Web of Science ®Google Scholar
• Maravic M, Ostertag A, Torres PU, et al. Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2014;25:159–165. doi:10.1007/s00198-013-2435-1
   PubMed Web of Science ®Google Scholar
• Huang P-H, Chen T-H, Lin Y-S, et al. Chronic kidney disease worsens health outcomes in diabetic patients after hip fracture surgery: an asian nationwide population-based cohort study. J Bone Miner Res off J Am Soc Bone Miner Res. 2019;34:849–858. doi:10.1002/jbmr.3663
   PubMed Web of Science ®Google Scholar
• Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–382. doi:10.1038/sj.ki.5000058
   PubMed Web of Science ®Google Scholar
• Jonsson AJ, Lund SH, Eriksen BO, et al. The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds. Kidney Int. 2020;98:1286–1295. doi:10.1016/j.kint.2020.06.017
   PubMed Web of Science ®Google Scholar
• Van Pottelbergh G, Van Heden L, Matheï C, et al. Methods to evaluate renal function in elderly patients: a systematic literature review. Age Ageing. 2010;39:542–548. doi:10.1093/ageing/afq091
   PubMed Web of Science ®Google Scholar
• Knapen MHJ, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2007;18:963–972. doi:10.1007/s00198-007-0337-9
   PubMed Web of Science ®Google Scholar
• Wray DW, Nishiyama SK, Harris RA, et al. Angiotensin II in the elderly: impact of angiotensin II type 1 receptor sensitivity on peripheral hemodynamics. Hypertens Dallas Tex. 2008;51:1611–1616. doi:10.1161/HYPERTENSIONAHA.108.111294
   PubMed Web of Science ®Google Scholar
• Dam -T-T, Peters KW, Fragala M, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol a Biol Sci Med Sci. 2014;69:584–590. doi:10.1093/gerona/glu013
   PubMed Web of Science ®Google Scholar
• Han D-S, Chen Y-M, Lin S-Y, et al. Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol (Oxf). 2011;75:857–863. doi:10.1111/j.1365-2265.2011.04120.x
   PubMed Web of Science ®Google Scholar
• Foley RN, Wang C, Ishani A, et al. Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol. 2007;27:279–286. doi:10.1159/000101827
   PubMed Web of Science ®Google Scholar
• West SL, Jamal SA, Lok CE. Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27:2384–2388.
   PubMed Web of Science ®Google Scholar
• Li M, Tomlinson G, Naglie G, et al. Geriatric comorbidities, such as falls, confer an independent mortality risk to elderly dialysis patients. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2008;23:1396–1400.
   PubMed Web of Science ®Google Scholar
• Desmet C, Beguin C, Swine C, et al. Falls in hemodialysis patients: prospective study of incidence, risk factors, and complications. Am J Kidney Dis off J Natl Kidney Found. 2005;45:148–153. doi:10.1053/j.ajkd.2004.09.027
   PubMed Web of Science ®Google Scholar
• Cook WL, Tomlinson G, Donaldson M, et al. Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol CJASN. 2006;1:1197–1204. doi:10.2215/CJN.01650506
   PubMed Web of Science ®Google Scholar
• Farragher J, Chiu E, Ulutas O, et al. Accidental falls and risk of mortality among older adults on chronic peritoneal dialysis. Clin J Am Soc Nephrol CJASN. 2014;9:1248–1253. doi:10.2215/CJN.11001013
   PubMed Web of Science ®Google Scholar
• Dukas L, Schacht E, Stähelin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 mL/min is a risk factor for falls and fractures. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2005;16:1683–1690.
   PubMed Web of Science ®Google Scholar
• Bowling CB, Bromfield SG, Colantonio LD, et al. Association of reduced eGFR and albuminuria with serious fall injuries among older adults. Clin J Am Soc Nephrol CJASN. 2016;11:1236–1243. doi:10.2215/CJN.11111015
   PubMed Web of Science ®Google Scholar
• Sedaghat S, Darweesh SKL, Verlinden VJA, et al. Kidney function, gait pattern and fall in the general population: a cohort study. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2018;33:2165–2172.
   PubMed Web of Science ®Google Scholar
• Verzola D, Procopio V, Sofia A, et al. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease. Kidney Int. 2011;79:773–782.
   PubMed Web of Science ®Google Scholar
• Nitsch D, Mylne A, Roderick PJ, et al. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2009;24:1539–1544.
   PubMed Web of Science ®Google Scholar
• Wang H, Ba Y, Xing Q, et al. Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 2019;9:e024067. doi:10.1136/bmjopen-2018-024067
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Lui L-Y, Taylor BC, et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007;167:133–139. doi:10.1001/archinte.167.2.133
   PubMedGoogle Scholar
• Naylor KL, McArthur E, Leslie WD, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86:810–818. doi:10.1038/ki.2013.547
   PubMed Web of Science ®Google Scholar
• Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006;17:3223–3232. doi:10.1681/ASN.2005111194
   PubMed Web of Science ®Google Scholar
• Cesini J, Cheriet S, Breuil V, et al. Osteoporosis: chronic kidney disease in rheumatology practice. Joint Bone Spine. 2012;79(Suppl 2):S104–109. doi:10.1016/S1297-319X(12)70017-9
   PubMed Web of Science ®Google Scholar
• Klawansky S, Komaroff E, Cavanaugh PF, et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2003;14:570–576. doi:10.1007/s00198-003-1435-y
   PubMed Web of Science ®Google Scholar
• Bikbov B, Perico N, Remuzzi G, et al. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the global burden of disease 2016 study. Nephron. 2018;139:313–318. doi:10.1159/000489897
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–1822. doi:10.1056/NEJMoa067312
   PubMed Web of Science ®Google Scholar
• Naylor KL, Garg AX, Zou G, et al. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol CJASN. 2015;10:646–653. doi:10.2215/CJN.06040614
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2007;18:1033–1046. doi:10.1007/s00198-007-0343-y
   PubMed Web of Science ®Google Scholar
• Fried LF, Biggs ML, Shlipak MG, et al. Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol JASN. 2007;18:282–286. doi:10.1681/ASN.2006050546
   PubMed Web of Science ®Google Scholar
• Cailleaux P-E, Ostertag A, Metzger M, et al. Longitudinal bone loss occurs at the radius in CKD. Kidney Int Rep. 2021;6:1525–1536.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Cunningham J, Ferrari S, et al. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2021;36:42–59.
   PubMed Web of Science ®Google Scholar
• Rix M, Andreassen H, Eskildsen P, et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56:1084–1093. doi:10.1046/j.1523-1755.1999.00617.x
   PubMed Web of Science ®Google Scholar
• Roetker NS, Peng Y, Ashfaq A, et al. Adherence to kidney disease: improving global outcomes mineral and bone guidelines for monitoring biochemical parameters. Am J Nephrol. 2019;49:225–232. doi:10.1159/000497477
   PubMed Web of Science ®Google Scholar
• Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31–38. doi:10.1038/sj.ki.5002009
   PubMed Web of Science ®Google Scholar
• Herberth J, Branscum AJ, Mawad H, et al. Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study. Am J Kidney Dis off J Natl Kidney Found. 2010;55:897–906. doi:10.1053/j.ajkd.2009.12.041
   PubMed Web of Science ®Google Scholar
• Nickolas TL, Cremers S, Zhang A, et al. Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol JASN. 2011;22:1560–1572. doi:10.1681/ASN.2010121275
   PubMed Web of Science ®Google Scholar
• Campos-Obando N, Koek WNH, Hooker ER, et al. Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS. J Bone Miner Res off J Am Soc Bone Miner Res. 2017;32:1182–1193. doi:10.1002/jbmr.3094
   PubMed Web of Science ®Google Scholar
• Gordon PL, Doyle JW, Johansen KL. Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4. J Ren Nutr off J Counc Ren Nutr Natl Kidney Found. 2012;22:423–433.
   Google Scholar
• He W, Kang YS, Dai C, et al. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol JASN. 2011;22:90–103. doi:10.1681/ASN.2009121236
   PubMed Web of Science ®Google Scholar
• Molina P, Carrero JJ, Bover J, et al. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2017;8:686–701. doi:10.1002/jcsm.12218
   PubMed Web of Science ®Google Scholar
• Elkasrawy MN, Hamrick MW. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010;10:56–63.
   PubMed Web of Science ®Google Scholar
• Mera P, Laue K, Ferron M, et al. Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. 2016;23:1078–1092. doi:10.1016/j.cmet.2016.05.004
   PubMed Web of Science ®Google Scholar
• Isakova T, Cai X, Lee J, et al. Associations of FGF23 with change in bone mineral density and fracture risk in older individuals. J Bone Miner Res off J Am Soc Bone Miner Res. 2016;31:742–748. doi:10.1002/jbmr.2750
   PubMed Web of Science ®Google Scholar
• Barker SL, Pastor J, Carranza D, et al. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. Nephrol Dial Transplant off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2015;30:223–233.
   PubMed Web of Science ®Google Scholar
• Han SG, Oh J, Jeon HJ, et al. Kidney stones and risk of osteoporotic fracture in chronic kidney disease. Sci Rep. 2019;9:1929. doi:10.1038/s41598-018-38191-1
   PubMed Web of Science ®Google Scholar
• Lehmann G, Ott U, Kaemmerer D, et al. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3–5. Clin Nephrol. 2008;70:296–305. doi:10.5414/CNP70296
   PubMed Web of Science ®Google Scholar
• Bhasin S, Gill TM, Reuben DB, et al. A randomized trial of a multifactorial strategy to prevent serious fall injuries. N Engl J Med. 2020;383:129–140. doi:10.1056/NEJMoa2002183
   PubMed Web of Science ®Google Scholar
• Howe TE, Shea B, Dawson LJ, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Musculoskeletal Group, editor. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD000333.pub2
   Web of Science ®Google Scholar
• Tentori F, Hunt WC, Stidley CA, et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2006;70:1858–1865. doi:10.1038/sj.ki.5001868
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med. 2006;166:424–430.
   PubMed Web of Science ®Google Scholar
• Taskapan H, Baysal O, Karahan D, et al. Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency. Clin Nephrol. 2011;76:110–116. doi:10.5414/CN107160
   PubMed Web of Science ®Google Scholar
• Zhao J-G, Zeng X-T, Wang J, et al. Association between calcium or Vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. JAMA. 2017;318:2466–2482. doi:10.1001/jama.2017.19344
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59. doi:10.1016/j.kisu.2017.04.001
   PubMed Web of Science ®Google Scholar
• Ureña P, Hruby M, Ferreira A, et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol JASN. 1996;7:506–512. doi:10.1681/ASN.V73506
   PubMed Web of Science ®Google Scholar
• Malluche HH, Mawad HW, Monier-Faugere M-C. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011;26:1368–1376. doi:10.1002/jbmr.309
   PubMed Web of Science ®Google Scholar
• Pfister T, Atzpodien E, Bohrmann B, et al. Acute renal effects of intravenous bisphosphonates in the rat. Basic Clin Pharmacol Toxicol. 2005;97:374–381. doi:10.1111/j.1742-7843.2005.pto_160.x
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Appel GB, Fine PL, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol JASN. 2001;12:1164–1172. doi:10.1681/ASN.V1261164
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Fine PL, Stack JI, et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 2003;64:281–289. doi:10.1046/j.1523-1755.2003.00071.x
   PubMed Web of Science ®Google Scholar
• Swallow EA, Aref MW, Metzger CE, et al. Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing. Bone. 2019;127:419–426. doi:10.1016/j.bone.2019.07.007
   PubMed Web of Science ®Google Scholar
• Miller PD, Roux C, Boonen S, et al. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res off J Am Soc Bone Miner Res. 2005;20:2105–2115. doi:10.1359/JBMR.050817
   PubMed Web of Science ®Google Scholar
• McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344:333–340.
   PubMed Web of Science ®Google Scholar
• Toussaint ND, Lau KK, Strauss BJ, et al. Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis off J Natl Kidney Found. 2010;56:57–68. doi:10.1053/j.ajkd.2009.12.039
   PubMed Web of Science ®Google Scholar
• Miller PD, Schwartz EN, Chen P, et al. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2007;18:59–68. doi:10.1007/s00198-006-0189-8
   PubMed Web of Science ®Google Scholar
• Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756–765. doi:10.1056/NEJMoa0809493
   PubMed Web of Science ®Google Scholar
• Hampson G, Elder GJ, Cohen-Solal M, et al. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease. Endocrine. 2021;73:509–529. doi:10.1007/s12020-021-02735-9
   PubMed Web of Science ®Google Scholar
• Khosla S, Farr JN, Tchkonia T, et al. The role of cellular senescence in ageing and endocrine disease. Nat Rev Endocrinol. 2020;16:263–275. doi:10.1038/s41574-020-0335-y
   PubMed Web of Science ®Google Scholar
• Farr JN, Xu M, Weivoda MM, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23:1072–1079. doi:10.1038/nm.4385
   PubMed Web of Science ®Google Scholar
• Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24:1246–1256. doi:10.1038/s41591-018-0092-9
   PubMed Web of Science ®Google Scholar
• Black DM, Cummings SR, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348(9041):1535‑1541. doi:10.1016/S0140-6736(96)07088-2
   Web of Science ®Google Scholar
• Black DM; Delmas, HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809‑1822. doi:10.1056/NEJMoa067312
   Web of Science ®Google Scholar
• Black DM, Thompson DE, Cummings SR. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. J Clin Endocrinol Metab. 2000;85(11):7.
   Web of Science ®Google Scholar
• Boonen S, Black DM, Colón-Emeric CS. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc. 2010;58(2):292‑299. doi:10.1111/j.1532-5415.2009.02673.x
   Web of Science ®Google Scholar
• Boonen S, McClung MR, Eastell R. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc. 2004;52(11):1832‑1839. doi:10.1111/j.1532-5415.2004.52506.x
   PubMed Web of Science ®Google Scholar
• Harris ST. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A Randomized Controlled Trial. JAMA. 1999;282(14):1344. doi:10.1001/jama.282.14.1344
   PubMed Web of Science ®Google Scholar
• Kendler DL, Marin F, Zerbini CAF. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391(10117):230‑240. doi:10.1016/S0140-6736(17)32137-2
   Web of Science ®Google Scholar
• Neer RM, Arnaud C, Mitlak BH. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434–1441.
   PubMed Web of Science ®Google Scholar
• Orwoll ES, Scheele WH, Paul GA. The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. J Bone Mineral Res. 2003;18(1):9‑17. doi:10.1359/jbmr.2003.18.1.9
   Web of Science ®Google Scholar